Strides CEO: US COMPETES Act Creates Quality Differentiator

Examining Upcoming HIV Therapies

 
• By Vibha Ravi

The $1-10m penalties prescribed on erring global manufacturers in the US COMPETES Act will create quality differentiators, Strides CEO R Ananthanarayanan tells Scrip. He also discusses the potential that Mark Cuban’s firm holds for Indian companies and Strides' evaluation of upcoming HIV therapies.

Concept Of Manufacturing In US
US COMPETES Act Has Implications For Manufacturing In US And Out • Source: Alamy

More from Manufacturing

More from Business